Literature DB >> 19839269

A combination DNA vaccine encoding nucleoside hydrolase 36 and glycoproteine 63 protects female but not male hamsters against Leishmania mexicana.

W G Chalé-Balboa1, M Mut-Martin, M J Ramirez-Sierra, M R Garcia-Miss, E Dumonteil.   

Abstract

Leishmaniasis is a group of diseases caused by protozoan parasites of the Leishmania genus. Previous studies have shown that a DNA vaccine encoding Leishmania donovani antigen nucleoside hydrolase 36 and L. mexicana glycoprotein 63 is protective in mice. We investigated here the efficacy of this DNA vaccine to induce protection in golden hamsters. Male hamsters were more susceptible to infection by Leishmania mexicana than females. Following immunization with two doses of the DNA vaccine, only females resulted protected while males developed normal lesions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19839269     DOI: 10.1051/parasite/2009163227

Source DB:  PubMed          Journal:  Parasite        ISSN: 1252-607X            Impact factor:   3.000


  6 in total

1.  Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.

Authors:  Dirlei Nico; Carla Claser; Gulnara P Borja-Cabrera; Luiz R Travassos; Marcos Palatnik; Irene da Silva Soares; Mauricio Martins Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

2.  The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.

Authors:  Kristina M Bacon; Peter J Hotez; Stephanie D Kruchten; Shaden Kamhawi; Maria Elena Bottazzi; Jesus G Valenzuela; Bruce Y Lee
Journal:  Vaccine       Date:  2012-11-20       Impact factor: 3.641

3.  Expression and purification of an engineered, yeast-expressed Leishmania donovani nucleoside hydrolase with immunogenic properties.

Authors:  Elissa M Hudspeth; Qian Wang; Christopher A Seid; Molly Hammond; Junfei Wei; Zhuyun Liu; Bin Zhan; Jeroen Pollet; Michael J Heffernan; C Patrick McAtee; David A Engler; Risë K Matsunami; Ulrich Strych; Oluwatoyin A Asojo; Peter J Hotez; Maria Elena Bottazzi
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

4.  Texas and Mexico: sharing a legacy of poverty and neglected tropical diseases.

Authors:  Peter J Hotez; Maria Elena Bottazzi; Eric Dumonteil; Jesus G Valenzuela; Shaden Kamhawi; Jaime Ortega; Samuel Ponce de Leon Rosales; Miguel Betancourt Cravioto; Roberto Tapia-Conyer
Journal:  PLoS Negl Trop Dis       Date:  2012-03-27

5.  Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Marcus Vinícius Alves-Silva; Elisangela Oliveira Freitas; Alexandre Morrot; Diana Bahia; Marcos Palatnik; Mauricio M Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-05-01       Impact factor: 7.561

6.  Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Iam Palatnik-de-Sousa; Alexandre Morrot; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-06-11       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.